Back to Journals » Drug Design, Development and Therapy » Volume 8
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
15,827 | Dovepress* | 14,870+ | 1,672 | 16,542 | |
PubMed Central* | 957 | 407 | 1,364 | ||
Totals | 15,827 | 2,079 | 17,906 | ||
*Since 12 December 2014 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 1 | 0 | 3 |
View citations on PubMed Central and Google Scholar